A "Smarter" Filler? Research on Niacinamide-Loaded Gels

A 2026 laboratory study tested an experimental hyaluronic acid filler with added niacinamide, a form of vitamin B3, to see whether it might resist bacteria and encourage collagen. In dishes and in small pieces of donated skin, the gel slowed the growth of two common bacteria and showed some signs of stimulating collagen. This is early laboratory work on a product that is not available to patients, and it is a long way from proving any benefit in people.

Why this was studied

Hyaluronic acid filler is widely used and generally well tolerated, but infection and inflammation are among the complications physicians work hardest to prevent. Bacteria introduced at the time of injection are thought to play a role in some delayed lumps and swelling. Our article on delayed filler reactions explains this in more detail.

Niacinamide is familiar to many people as a skincare ingredient. Research suggests it has anti-inflammatory properties and may support the skin barrier. Our article on niacinamide covers its role in topical skincare. The researchers wanted to know whether building niacinamide into a filler could add protective or skin-boosting properties.

What the researchers did

The team worked with an experimental cross-linked hyaluronic acid gel containing niacinamide and a numbing agent. They measured its physical properties, including firmness, and checked that these stayed stable after two years of storage. They compared it in several tests with a commercially available hyaluronic acid filler that contains no niacinamide.

Tests included:

• bacterial growth experiments with two common species, one of which is a frequent cause of skin infections
• immune cell experiments to look at inflammatory signals
• safety checks on skin cells and red blood cells
• small pieces of donated human skin, kept alive in the laboratory for eight days, to look for changes in collagen

What they found

The niacinamide gel reduced growth of one bacterial species by about 90% and the other by about half in these laboratory tests. The comparison filler also had some effect, which is interesting in itself. In immune cell experiments, the gel lowered some inflammatory signals, though less than niacinamide alone, probably because the gel holds onto the vitamin rather than releasing it all at once.

In the donated skin samples, there were signs of more type I collagen after eight days, though results depended on how collagen was measured and not every measure reached statistical significance. The gel did not harm skin cells or red blood cells in the safety tests. Interestingly, niacinamide on its own was harmful to cells at higher concentrations, which shows why careful formulation matters.

How strong is this evidence?

This study sits at the very beginning of the research pathway. Laboratory results like these help scientists decide whether an idea is worth testing further. They cannot show that a product is safe or effective in people. Important limits include:

• No animals or human participants were involved.
• Skin samples came from a single donor, and many tests used only three samples per group.
• Eight days is very short for assessing collagen change.
• The design could not separate the effect of niacinamide from the hyaluronic acid gel itself in the skin samples.
• Bacterial tests in a dish lack the immune system that would be present in real tissue.
• Commercial interest. The gel was supplied by the company that makes and holds the patent for it, and three authors work part-time for that company.

None of this means the research is wrong. It means that bigger, independent and eventually human studies are needed before drawing conclusions.

What it means for you

This experimental filler is not available, is not authorized by Health Canada, and is not offered by HealthPark. Please do not seek it, or any "enhanced" filler, from online sellers or unregulated sources. Fillers are medical devices, and their safety depends on careful manufacturing, regulation and trained injectors.

It is also worth knowing that the practical steps that reduce infection risk with today's fillers are well established. These include thorough skin cleansing, sterile technique, avoiding treatment when there is an active infection nearby, and good aftercare such as keeping the area clean and avoiding makeup for the first several hours. People who are pregnant or breastfeeding, who have active cold sores or skin infections, or who have certain autoimmune conditions should discuss timing and suitability first.

Applying niacinamide skincare will not change how filler behaves under the skin. It remains a reasonable topical ingredient for some people, particularly for redness, oiliness or uneven tone, but its effects on the skin surface are a separate topic from what happens to an injected gel.

Questions to ask at your consultation

• What steps do you take to reduce the risk of infection with filler?
• How should I care for the area in the first day or two after treatment?
• What signs of infection or inflammation should I report, and how quickly?
• Is the product you are recommending authorized by Health Canada?

Frequently asked questions

Will "smart" fillers be available soon?

It is hard to say. Most laboratory discoveries never become products. Those that do typically take years of animal and human testing before regulators review them.

Does a filler that fights bacteria mean infections will disappear?

Even if this approach works in people, it would add to, not replace, careful technique and hygiene. Infection after filler is uncommon, and prevention depends mostly on how treatment is done.

Can I mix niacinamide serum with filler myself?

No. Never inject or apply anything into or onto freshly treated skin unless your clinician has advised it. Home mixing is unsafe.

Laboratory research like this shows where filler science may be heading, but today's decisions should rest on proven products and careful care. If you have questions about filler safety, HealthPark Medical Aesthetics can discuss them with you at a consultation.

Source

Porcello A, Schelker C, Jordan O, Perron K, Sublet E, Martignago CCS, Marques C, Applegate LA, Laurent AE, Patrulea V. A smarter dermal filler: antimicrobial protection and collagen stimulation with niacinamide. European Journal of Pharmaceutics and Biopharmaceutics, 2026. Read the study